Avitide Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 29

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $275M

Avitide General Information

Description

Developer a molecule-specific affinity purification technology designed to improve drug safety and establish bio similarity. The company's technology focuses on purifying therapeutic proteins, and uses rapid development of chromatography resins via chemical synthesis, enabling partners to achieve speeded bioprocess development timelines, reduced program risk, predictable commercial scalability, and lower cost of manufacturing for batch and continuous operations.

Contact Information

Website
www.avitide.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 16 Cavendish Court
  • Lebanon, NH 03766
  • United States
+1 (603)
Primary Industry
Biotechnology
Parent Company
Repligen
Vertical(s)
Life Sciences
Corporate Office
  • 16 Cavendish Court
  • Lebanon, NH 03766
  • United States
+1 (603)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avitide Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 30-Sep-2021 $275M Completed Generating Revenue
8. Later Stage VC (Series H) 23-Oct-2019 Completed Generating Revenue
7. Later Stage VC (Series G) 23-Aug-2018 Completed Generating Revenue
6. Later Stage VC (Series F) 02-Jan-2018 Completed Generating Revenue
5. Later Stage VC (Series E) 26-Jun-2017 Completed Generating Revenue
4. Later Stage VC (Series D) 12-Sep-2016 Completed Generating Revenue
3. Later Stage VC (Series C) 06-Aug-2015 Completed Generating Revenue
2. Early Stage VC (Series B) 09-Jun-2014 $3.44M $4.89M Completed Startup
1. Early Stage VC (Series A) 04-Mar-2013 $1.45M $1.45M Completed Startup
To view Avitide’s complete valuation and funding history, request access »

Avitide Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series H
Series G
Series F
Series E
Series D
Series C
Series B 918,450 $0.000100 $3.74 $3.74 1x $3.74 10.92%
Series A 783,422 $0.000100 $1.87 $1.87 1x $1.87 9.32%
To view Avitide’s complete cap table history, request access »

Avitide Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer a molecule-specific affinity purification technology designed to improve drug safety and establish bio similar
Biotechnology
Lebanon, NH
29 As of 2024

Seoul, South Korea
 

Castel Maggiore, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avitide Competitors (25)

One of Avitide’s 25 competitors is ToolGen, a Corporation company based in Seoul, South Korea.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ToolGen Corporation Seoul, South Korea
Menarini Silicon Biosystems Formerly VC-backed Castel Maggiore, Italy
Egenesis Venture Capital-Backed Cambridge, MA
Quantapore Venture Capital-Backed South San Francisco, CA
Sphere Fluidics Venture Capital-Backed Cambridge, United Kingdom
You’re viewing 5 of 25 competitors. Get the full list »

Avitide Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avitide Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angeli Parvi Angel Group Minority
Borealis Ventures Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Mithril Capital Management Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Avitide FAQs

  • When was Avitide founded?

    Avitide was founded in 2012.

  • Where is Avitide headquartered?

    Avitide is headquartered in Lebanon, NH.

  • What is the size of Avitide?

    Avitide has 29 total employees.

  • What industry is Avitide in?

    Avitide’s primary industry is Biotechnology.

  • Is Avitide a private or public company?

    Avitide is a Private company.

  • What is the current valuation of Avitide?

    The current valuation of Avitide is .

  • What is Avitide’s current revenue?

    The current revenue for Avitide is .

  • How much funding has Avitide raised over time?

    Avitide has raised $48.7M.

  • Who are Avitide’s investors?

    Angeli Parvi, Borealis Ventures, , , and Mithril Capital Management are 5 of 12 investors who have invested in Avitide.

  • Who are Avitide’s competitors?

    ToolGen, Menarini Silicon Biosystems, Egenesis, Quantapore, and Sphere Fluidics are some of the 25 competitors of Avitide.

  • When was Avitide acquired?

    Avitide was acquired on 30-Sep-2021.

  • Who acquired Avitide?

    Avitide was acquired by Repligen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »